Literature DB >> 21946693

Angiotensin II-dependent hypertension causes reversible changes in the platelet proteome.

Simon Gebhard1, Leif Steil, Barbara Peters, Manuela Gesell-Salazar, Elke Hammer, Beate Kuttler, Kenneth J Clemetson, Christian Scharf, Jörg Peters, Uwe Völker, Rainer Rettig, Andreas Greinacher.   

Abstract

OBJECTIVE: Hypertension is a risk factor for arterial thrombosis. We investigated the effects of angiotensin II (ANG II)-dependent hypertension on the platelet proteome. METHODS AND
RESULTS: Hypertension was induced in cyp1a1ren-2 transgenic rats by feeding indole-3-carbinol (n = 10) and in Fischer 344 rats by subcutaneously infusing ANG II (n = 7). After 14 days of hypertension (SBP 180 mmHg) and 10 days after normalization of blood pressure, changes in the platelet proteome were assessed by two-dimensional differential in-gel electrophoresis. In a subset of animals (n = 4), repeated blood withdrawals were performed. Of 1040 protein spots, 45 displayed hypertension-associated changes (>1.5-fold, P < 0.01) in both models (34 increased, 11 decreased). All were reversible within 10 days. Thirty-eight spots were identified by mass spectrometry and assigned to 20 distinct proteins. The majority of spots with increased intensity constituted protein fragments. Repeated blood withdrawals and stimulation of megakaryocytopoiesis by a thrombopoietin receptor agonist induced changes in the same protein spots but in the opposite direction to those induced by ANG II-dependent hypertension.
CONCLUSION: ANG II-dependent hypertension is associated with enhanced protein degradation in platelets. As these changes are reversible, the proteins identified might be used to develop a biomarker for monitoring recent blood pressure history.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21946693     DOI: 10.1097/HJH.0b013e32834b1991

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

Review 1.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 2.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

3.  Differentially expressed proteins in platelets derived from patients with hypertension.

Authors:  Yobana Armenta-Medina; Ivette Martínez-Vieyra; Oscar Medina-Contreras; Claudia G Benitez-Cardoza; Albertana Jiménez-Pineda; César A Reyes-López; Doris Cerecedo
Journal:  J Hum Hypertens       Date:  2021-07-03       Impact factor: 2.877

Review 4.  Effects of hypertension and exercise on cardiac proteome remodelling.

Authors:  Bernardo A Petriz; Octavio L Franco
Journal:  Biomed Res Int       Date:  2014-04-27       Impact factor: 3.411

Review 5.  Toward the Relevance of Platelet Subpopulations for Transfusion Medicine.

Authors:  Stefan Handtke; Leif Steil; Andreas Greinacher; Thomas Thiele
Journal:  Front Med (Lausanne)       Date:  2018-02-05

Review 6.  Utilizing proteomics to understand and define hypertension: where are we and where do we go?

Authors:  Christian Delles; Emma Carrick; Delyth Graham; Stuart A Nicklin
Journal:  Expert Rev Proteomics       Date:  2018-07-12       Impact factor: 3.940

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.